Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. ADA Action Center

Tirzepatides & Therapeutic Inertia: Highlights from ADA

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    From newly approved treatments to emerging clinical trial data, Dr. Carol Wysham shares some of the highlights from the American Diabetes Association’s 82nd Scientific Sessions, exploring developments in GLP-1 receptor agonists, barriers to patient use, and more.

Recommended
Details
Presenters
Comments
  • Overview

    From newly approved treatments to emerging clinical trial data, Dr. Carol Wysham shares some of the highlights from the American Diabetes Association’s 82nd Scientific Sessions, exploring developments in GLP-1 receptor agonists, barriers to patient use, and more.

Schedule5 Oct 2024